Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.
Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, Caratelli S, Spagnoli GC, Lauro D, Lugli A, Han J, Iezzi G, Ferrone C, Ferlosio A, Tornillo L, Droeser R, Rossi P, Attanasio A, Ferrone S, Terracciano L. Sconocchia G, et al. Neoplasia. 2014 Jan;16(1):31-42. doi: 10.1593/neo.131568. Neoplasia. 2014. PMID: 24563618 Free PMC article.
HLA-DRB1*13:01 allele in the genetic susceptibility to colorectal carcinoma.
Aureli A, Canossi A, Del Beato T, Franceschilli L, Buonomo O, Papola F, De Sanctis F, Lanzilli G, Sileri P, Coppola A, Caratelli S, Arriga R, Orlandi A, Lauro D, Rossi P, Sconocchia G. Aureli A, et al. Among authors: sconocchia g. Int J Cancer. 2015 May 15;136(10):2464-8. doi: 10.1002/ijc.29285. Epub 2014 Oct 30. Int J Cancer. 2015. PMID: 25346274
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients.
Benvenuto M, Sileri P, Rossi P, Masuelli L, Fantini M, Nanni M, Franceschilli L, Sconocchia G, Lanzilli G, Arriga R, Faggioni G, Lista F, Orlandi A, Manzari V, Gaspari AL, Modesti A, Bei R. Benvenuto M, et al. Among authors: sconocchia g. J Transl Med. 2015 Mar 28;13:101. doi: 10.1186/s12967-015-0455-7. J Transl Med. 2015. PMID: 25889931 Free PMC article.
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
Arriga R, Caratelli S, Lanzilli G, Ottaviani A, Cenciarelli C, Sconocchia T, Spagnoli GC, Iezzi G, Roselli M, Lauro D, Coppola A, Dotti G, Ferrone S, Sconocchia G. Arriga R, et al. Among authors: sconocchia t, sconocchia g. Int J Cancer. 2020 May 1;146(9):2531-2538. doi: 10.1002/ijc.32618. Epub 2019 Aug 30. Int J Cancer. 2020. PMID: 31396956 Free PMC article.
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia.
Aureli A, Marziani B, Sconocchia T, Del Principe MI, Buzzatti E, Pasqualone G, Venditti A, Sconocchia G. Aureli A, et al. Among authors: sconocchia t, sconocchia g. Cancers (Basel). 2021 Dec 13;13(24):6246. doi: 10.3390/cancers13246246. Cancers (Basel). 2021. PMID: 34944865 Free PMC article. Review.
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.
Sconocchia G, Lanzilli G, Cesarini V, Silvestris DA, Rezvani K, Arriga R, Caratelli S, Chen K, Dou J, Cenciarelli C, Toietta G, Baldari S, Sconocchia T, De Paolis F, Aureli A, Iezzi G, Irno Consalvo M, Buccisano F, Del Principe MI, Maurillo L, Venditti A, Ottaviani A, Spagnoli GC. Sconocchia G, et al. Life Sci Alliance. 2022 Oct 14;5(12):e202201590. doi: 10.26508/lsa.202201590. Print 2022 Dec. Life Sci Alliance. 2022. PMID: 36241426 Free PMC article.
99 results